Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis

被引:191
|
作者
Gao, YK
Herndon, JM
Zhang, H
Griffith, TS
Ferguson, TA
机构
[1] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA
[2] Washington Univ, Sch Med, Dept Pathol, St Louis, MO 63110 USA
来源
JOURNAL OF EXPERIMENTAL MEDICINE | 1998年 / 188卷 / 05期
关键词
apoptosis; inflammation; immune privilege; FasL; interleukin-10;
D O I
10.1084/jem.188.5.887
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Apoptosis is critical to homeostasis of multicellular organisms. In immune privileged sites such as the eye, CD95 ligand (FasL)-induced apoptosis controls dangerous inflammatory reactions that can cause blindness. Recently, we demonstrated that apoptotic cell death of inflammatory cells was a prerequisite for the induction of immune deviation after antigen presentation in the eye. In this report, we examine the mechanism by which this takes place. Our results show that Fas-mediated apoptosis of lymphoid cells leads to rapid production of interleukin (IL)-10 in these cells. The apoptotic cells containing IL-10 are responsible for the activation of immune deviation through interaction with antigen-presenting cells (APC). In support of this, we found that apoptotic cells from IL-10(+/+) animals fed to APC in vitro promote Th2 cell differentiation, whereas apoptotic IL-10(-/-) cells, as well as nonapoptotic cells, favor Th1 induction. Thus, apoptotic cell death and tolerance are linked through the production of an antiinflammatory cytokine to prevent dangerous and unwanted immune responses that might compromise organ integrity.
引用
收藏
页码:887 / 896
页数:10
相关论文
共 50 条
  • [1] CD95 ligand (FasL)-induced apoptosis is necessary for corneal allograft survival
    Stuart, PM
    Griffith, TS
    Usui, N
    Pepose, J
    Yu, XH
    Ferguson, TA
    JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (03): : 396 - 402
  • [2] Role of the CD95/CD95 ligand system in glucocorticoid-induced monocyte apoptosis
    Schmidt, M
    Lügering, N
    Lügering, A
    Pauels, HG
    Schulze-Osthoff, K
    Domschke, W
    Kucharzik, T
    JOURNAL OF IMMUNOLOGY, 2001, 166 (02): : 1344 - 1351
  • [3] Death Induced by CD95 or CD95 Ligand Elimination
    Hadji, Abbas
    Ceppi, Paolo
    Murmann, Andrea E.
    Brockway, Sonia
    Pattanayak, Abhinandan
    Bhinder, Bhavneet
    Hau, Annika
    De Chant, Shirley
    Parimi, Vamsi
    Kolesza, Piotre
    Richards, JoAnne
    Chandel, Navdeep
    Djaballah, Hakim
    Peter, Marcus E.
    CELL REPORTS, 2014, 7 (01): : 208 - 222
  • [4] THE FAS LIGAND (FASL)-GAS (CD95) SYSTEM IN THE KIDNEY
    GONZALEZCUADRADO, S
    ORTIZ, A
    KARP, S
    LI, S
    CIZMAN, B
    LOPEZARMADA, MJ
    MADAIO, M
    EGIDO, J
    NEILSON, EG
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1994, 5 (03): : 748 - 748
  • [5] CD95 ligand-induced apoptosis of human medulloblastoma cells
    Weller, M
    Schuster, M
    Pietsch, T
    Schabet, M
    CANCER LETTERS, 1998, 128 (02) : 121 - 126
  • [6] Characterization of CD95 ligand (CD95L)-induced apoptosis in human tenon fibroblasts
    Hueber, A
    Welsandt, G
    Jordan, JF
    Mietz, H
    Weller, M
    Krieglstein, GK
    Esser, PJ
    EXPERIMENTAL EYE RESEARCH, 2002, 75 (01) : 1 - 8
  • [7] CD95 ligand (FasL;Apol-L) associated proteins
    Barth, JT
    Schaetzlein, C
    Radons, J
    Peter, HH
    Eibel, H
    FASEB JOURNAL, 1999, 13 (05): : A995 - A995
  • [8] The role of CD95 and CD95 ligand in cancer
    M E Peter
    A Hadji
    A E Murmann
    S Brockway
    W Putzbach
    A Pattanayak
    P Ceppi
    Cell Death & Differentiation, 2015, 22 : 549 - 559
  • [9] Human tumor cells do not express CD95 ligand (FasL)
    Chen, CM
    Song, WY
    Kao, J
    Zheng, QD
    Chen, JJ
    GASTROENTEROLOGY, 2001, 120 (05) : A666 - A666
  • [10] The role of CD95 and CD95 ligand in cancer
    Peter, M. E.
    Hadji, A.
    Murmann, A. E.
    Brockway, S.
    Putzbach, W.
    Pattanayak, A.
    Ceppi, P.
    CELL DEATH AND DIFFERENTIATION, 2015, 22 (04): : 549 - 559